AAAAAA
Results:
1-22
|
Results: 22
Authors:
Melton, LJ
Orwoll, ES
Wasnich, RD
Citation: Lj. Melton et al., Does bone density predict fractures comparably in men and women?, OSTEOPOR IN, 12(9), 2001, pp. 707-709
Authors:
Aoyagi, K
Ross, PD
Orloff, J
Davis, JW
Katagiri, H
Wasnich, RD
Citation: K. Aoyagi et al., Low bone density is not associated with aortic calcification, CALCIF TIS, 69(1), 2001, pp. 20-24
Authors:
Tsuzuku, S
Shimokata, H
Ikegami, Y
Yabe, K
Wasnich, RD
Citation: S. Tsuzuku et al., Effects of high versus low-intensity resistance training on bone mineral density in young males, CALCIF TIS, 68(6), 2001, pp. 342-347
Authors:
Hla, MM
Davis, JW
Ross, PD
Yates, AJ
Wasnich, RD
Citation: Mm. Hla et al., The relation between lifestyle factors and biochemical markers of bone turnover among early postmenopausal women, CALCIF TIS, 68(5), 2001, pp. 291-296
Authors:
McClung, MR
Geusens, P
Miller, PD
Zippel, H
Bensen, WG
Roux, C
Adami, S
Fogelman, I
Diamond, T
Eastell, R
Meunier, PJ
Reginster, JY
Wasnich, RD
Greenwald, M
Kaufman, J
Chestnut, CH
Citation: Mr. Mcclung et al., Effect of risedronate on the risk of hip fracture in elderly women, N ENG J MED, 344(5), 2001, pp. 333-340
Authors:
Hla, MM
Davis, JW
Ross, PD
Yates, J
Wasnich, RD
Ravn, P
McClung, M
Hosking, D
Citation: Mm. Hla et al., Relation between body composition and biochemical markers of bone turnoveramong early postmenopausal women, J CLIN DENS, 3(4), 2000, pp. 365-371
Authors:
Ross, PD
Kress, BC
Parson, RE
Wasnich, RD
Armour, KA
Mizrahi, IA
Citation: Pd. Ross et al., Serum bone alkaline phosphatase and calcaneus bone density predict fractures: A prospective study, OSTEOPOR IN, 11(1), 2000, pp. 76-82
Authors:
Tonino, RP
Meunier, PJ
Emkey, R
Rodriguez-Portales, JA
Menkes, CJ
Wasnich, RD
Bone, HG
Santora, AC
Wu, M
Desai, R
Ross, PD
Citation: Rp. Tonino et al., Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women, J CLIN END, 85(9), 2000, pp. 3109-3115
Authors:
Ravn, P
Weiss, SR
Rodriguez-Portales, JA
McClung, MR
Wasnich, RD
Gilchrist, NL
Sambrook, P
Fogelman, I
Krupa, D
Yates, AJ
Daifotis, A
Fuleihan, GE
Citation: P. Ravn et al., Alendronate in early postmenopausal women: Effects on bone mass during long-term treatment and after withdrawal, J CLIN END, 85(4), 2000, pp. 1492-1497
Authors:
Wasnich, RD
Miller, PD
Citation: Rd. Wasnich et Pd. Miller, Antifracture efficacy of antiresorptive agents are related to changes in bone density, J CLIN END, 85(1), 2000, pp. 231-236
Authors:
Ravn, P
Wasnich, RD
Cizza, G
Citation: P. Ravn et al., Long-term prevention of bone loss - In response, ANN INT MED, 133(1), 2000, pp. 72-73
Authors:
Davis, JW
Grove, JS
Wasnich, RD
Ross, PD
Citation: Jw. Davis et al., Spatial relationships between prevalent and incident spine fractures, BONE, 24(3), 1999, pp. 261-264
Authors:
Davis, JW
Nevitt, MC
Wasnich, RD
Ross, PD
Citation: Jw. Davis et al., A cross-cultural comparison of neuromuscular performance, functional status, and falls between Japanese and white women, J GERONT A, 54(6), 1999, pp. M288-M292
Authors:
Wasnich, RD
Ross, PD
Thompson, DE
Cizza, G
Yates, AJ
Citation: Rd. Wasnich et al., Skeletal benefits of two years of alendronate treatment are similar for early postmenopausal Asian and Caucasian women, OSTEOPOR IN, 9(5), 1999, pp. 455-460
Authors:
Ravn, P
Cizza, G
Bjarnason, NH
Thompson, D
Daley, M
Wasnich, RD
McClung, M
Hosking, D
Yates, AJ
Christiansen, C
Citation: P. Ravn et al., Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women, J BONE MIN, 14(9), 1999, pp. 1622-1627
Authors:
Davis, JW
Novotny, R
Wasnich, RD
Ross, PD
Citation: Jw. Davis et al., Ethnic, anthropometric, and lifestyle associations with regional variations in peak bone mass, CALCIF TIS, 65(2), 1999, pp. 100-105
Authors:
Meunier, PJ
Delmas, PD
Eastell, R
McClung, MR
Papapoulos, S
Rizzoli, R
Seeman, E
Wasnich, RD
Citation: Pj. Meunier et al., Diagnosis and management of osteoporosis in postmenopausal women: Clinicalguidelines, CLIN THER, 21(6), 1999, pp. 1025-1044
Authors:
Ravn, P
Hosking, D
Thompson, D
Cizza, G
Wasnich, RD
McClung, M
Yates, AJ
Bjarnason, NH
Christiansen, C
Citation: P. Ravn et al., Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study, J CLIN END, 84(7), 1999, pp. 2363-2368
Authors:
Aoyagi, K
Ross, PD
Huang, C
Wasnich, RD
Hayashi, T
Takemoto, T
Citation: K. Aoyagi et al., Prevalence of joint pain is higher among women in rural Japan than urban Japanese-American women in Hawaii, ANN RHEUM D, 58(5), 1999, pp. 315-319
Authors:
Ravn, P
Bidstrup, M
Wasnich, RD
Davis, JW
McClung, MR
Balske, A
Coupland, C
Sahota, O
Kaur, A
Daley, M
Cizza, G
Citation: P. Ravn et al., Alendronate and estrogen-progestin in the long-term prevention of bone loss: Four-year results from the early postmenopausal intervention cohort study - A randomized, controlled trial, ANN INT MED, 131(12), 1999, pp. 935
Authors:
Davis, JW
Ross, PD
Nevitt, MC
Wasnich, RD
Citation: Jw. Davis et al., Risk factors for falls and for serious injuries on falling among older Japanese women in Hawaii, J AM GER SO, 47(7), 1999, pp. 792-798
Authors:
Wasnich, RD
Citation: Rd. Wasnich, Perspective on fracture risk and phalangeal bone mineral density, J CLIN DENS, 1(3), 1998, pp. 259-268
Risultati:
1-22
|